HOME › Press Releases › Interventional Cardiology and Peripheral Vascular Devices Market worth $26.72 Billion by 2019
Interventional Cardiology and Peripheral Vascular Devices Market worth $26.72 Billion by 2019
The report “Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market along with the estimates and forecasts of the revenue and market share analysis.
Browse 152 market data tables and 50 figures spread through 163 pages and in-depth TOC on “Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019"
Early buyers will receive 10% customization on reports.
The global interventional cardiology and peripheral vascular devices market is expected to reach $26.72 Billion by 2019 from $18.73 Billion in 2014, at a CAGR of 7.4% from 2014 to 2019.
The report segments this market based on products that include angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Among various products, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to the increasing company investments to develop new stents with better clinical outcomes.
Based on geography, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this geographic segment is driven by factors such as rising incidence of cardiovascular diseases, rising aging population base, and technological advancements.
Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252